Finnegan Partner Leslie McDonell Named a Global Leader by Intellectual Asset Management

Finnegan partner Leslie McDonell is named on the IAM Strategy 300: Global Leaders list, which identifies professionals whose approach to intellectual property is regarded by peers as truly strategic in nature. Individuals are selected based on multiple nominations that highlight attorneys with proven track records protecting, advocating, and leveraging the value of IP for clients.

Leslie provides strategic  counseling on the procurement and protection of intellectual property to clients in the pharmaceutical and biotechnology industries  She has extensive experience  conducting and preparing companies for due diligence investigations, pre-litigation analyses, and offensive and defensive post-grant proceedings.

Leslie has represented clients before the U.S. Patent and Trademark Office (USPTO) in patent appeals, interferences, reissues, reexaminations, and inter partes reviews (IPRs). Her U.S. litigation experience includes representation of both plaintiffs and defendants in biotechnology and pharmaceutical cases. She coordinates worldwide patent portfolio strategies, evaluates, and analyzes competitors’ patent positions around the world; and advises and renders opinions on issues of patentability, inventorship, validity, claim scope, infringement, and freedom-to-operate.